Elie Ferneini
Oral and Maxillofacial Surgery · Cheshire, CTNPI 1992997050
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,146 of the $13,451 with a category attached, or 82.9%. 15 manufacturers reported payments, led by Zimvie Inc. at 44.8% of the total. Reporting peaked in 2022 at $3,494 and has fallen 78.8% since, to $741 in 2025. Among oral and maxillofacial surgery clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 194 payments — averaging $69.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimvie Inc.$6K
- Merz North America, Inc.$3K
- Zimmer Biomet$2K
- Colgate Oral Pharmaceuticals, Inc.$1K
- Intersect ENT, Inc.$424
- AbbVie$166
- plus $428 from 9 others
What the payments were for
- Consulting fees$1,0007%
- Travel & lodging$1,0568%
- Food & beverage$11,14683%
- Education$2502%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimvie Inc. | 87 | $6,032 |
| Merz North America, Inc. | 36 | $3,309 |
| Zimmer Biomet | 40 | $2,092 |
| Colgate Oral Pharmaceuticals, Inc. | 1 | $1,000 |
| Intersect ENT, Inc. | 5 | $424 |
| AbbVie(2 entities) | 5 | $166 |
| Geistlich Pharma, North America, Inc. | 7 | $128 |
| Pfizer | 5 | $92 |
| Aerin Medical Inc. | 2 | $72 |
| Straumann USA LLC | 1 | $36 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Medtronic | 1 | $22 |
| Nobel Biocare USA | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| ACE Surgical Supply Co., Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$2,205
- Bellatek$442
- Virtual Implant Planning$332
- SINUVA$274
- ASCLERA$250
- RealGUIDE IMPLANT MOUNT$246
- 3i T3$234
- NAVIGATOR CERTAIN$219
- Navigator System$207
- 3DIEMME RealGUIDE$139
- All T3 Implants$107
- T3$103
How this compares
$13,451 in reported general payments places this provider in the 95th percentile of 101 oral and maxillofacial surgery providers in Connecticut.
See all oral and maxillofacial surgery providers in Connecticut →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorhexidine Gluconate | 328 | $879 |
| Lidocaine Hcl ViscousLidocaine Hcl | 94 | $825 |
| Dexamethasone | 30 | $485 |
| Amoxicillin | 310 | $471 |
| Ibuprofen | 190 | $367 |
| Nystatin | 12 | $193 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 23 | $130 |
| Azithromycin | 64 | $107 |
| Clindamycin Hcl | 14 | $61 |
| IbuIbuprofen | 16 | $25 |
| Meloxicam | 17 | $22 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Cheshire
- Stuart LieblichAvon$86K
- Michael FormanGreenwich$30K
- Seth MattonEast Lyme$9K
- Michael JohnsonGuilford$8K
- Simon BangiyevNorwalk$5K
- Drew WeymanFarmington$4K
- Thomas WilsonGreenwich$4K
- Jordan GreenbergBranford$4K
- Joel RosenlichtManchester$4K
- David GreenmanSouth Norwalk$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.